AllSight
Companies · LIVN · Electromedical & Electrotherapeutic Apparatus

LivaNova PLC (LIVN)

LivaNova PLC (LIVN) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

LivaNova PLC (LIVN) stock — financials & valuation

Key numbers for LivaNova PLC (LIVN): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 57/100 — a percentile rank of LivaNova PLC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$4.1B
P / E21.8×
P / S2.8×
EV / EBITDA16.2×
Gross margin68.1%
Operating margin12.7%
Net margin12.8%
Return on equity14.2%
ROIC30.0%
Revenue growth12.4%
Debt / equity0.2×
Dividend yield0.0%

Is LivaNova PLC overvalued? P/S looks fair vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from LivaNova PLC’s own financial statements and shown as context, never as advice.

Aug 5, 2026
Guidance rises after broad beat, though cash outlook retreats
Related companies in Electromedical & Electrotherapeutic Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact